- Clinical Trials
- May 2020
- 423 Pages
Global
From €2418EUR$2,500USD£2,072GBP
- Clinical Trials
- May 2020
- 322 Pages
Global
From €2418EUR$2,500USD£2,072GBP
- Drug Pipelines
- October 2020
- 71 Pages
Global
From €3385EUR$3,500USD£2,901GBP
- Drug Pipelines
- September 2020
- 35 Pages
Global
From €1934EUR$2,000USD£1,658GBP
- Drug Pipelines
- September 2020
- 40 Pages
Global
From €1934EUR$2,000USD£1,658GBP
- Report
- January 2019
- 92 Pages
Global
From €3143EUR$3,250USD£2,694GBP
- Report
- May 2023
- 79 Pages
Global
From €3500EUR$3,877USD£3,105GBP
- Report
- May 2023
- 81 Pages
Global
From €3500EUR$3,877USD£3,105GBP
- Report
- August 2022
- 92 Pages
Global
From €3385EUR$3,500USD£2,901GBP
- Report
- May 2022
- 40 Pages
Global
From €1934EUR$2,000USD£1,658GBP
- Report
- May 2022
- 40 Pages
Global
From €1934EUR$2,000USD£1,658GBP
- Report
- May 2022
- 151 Pages
Global
From €2418EUR$2,500USD£2,072GBP
- Report
- May 2022
- 49 Pages
Global
From €1934EUR$2,000USD£1,658GBP
- Report
- February 2024
- 218 Pages
Global
From €3481EUR$3,600USD£2,984GBP
The Thrombosis Drug market is a subset of the Cardiovascular Drugs market, which focuses on the prevention and treatment of blood clots. Thrombosis drugs are used to reduce the risk of stroke, heart attack, and other cardiovascular events. These drugs work by preventing the formation of blood clots, or by dissolving existing clots. Commonly used thrombosis drugs include anticoagulants, antiplatelet agents, and thrombolytics. Anticoagulants, such as warfarin and heparin, are used to prevent the formation of blood clots. Antiplatelet agents, such as aspirin and clopidogrel, are used to prevent the formation of clots in the arteries. Thrombolytics, such as alteplase and streptokinase, are used to dissolve existing clots.
Some companies in the Thrombosis Drug market include Bayer, Pfizer, Sanofi, Bristol-Myers Squibb, and Merck. Show Less Read more
